Folate Receptor α - A New Target for an Old Enemy
Ovarian cancer remains one of the biggest challenges in daily gynaeco-oncologic practice due to its high morbidity and mortality. Platinum-based chemotherapy regimens have been the mainstay of advanced ovarian cancer treatment for several decades. However, up to 85% of the patients with advanced dis...
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
THE HEALTHBOOK COMPANY LTD.
2020-10-01
|
| Series: | healthbook TIMES. Oncology Hematology |
| Online Access: | https://doi.org/10.36000/hbT.OH.2020.05.022 |